These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 2905529

  • 1. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P.
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [Abstract] [Full Text] [Related]

  • 2. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 3. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P.
    Psychopharmacology Suppl; 1985 Jun; 2():1-8. PubMed ID: 3159008
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA.
    Br J Psychiatry Suppl; 1994 Apr 30; (23):65-70. PubMed ID: 7913610
    [Abstract] [Full Text] [Related]

  • 6. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T, Seeman P.
    Adv Biochem Psychopharmacol; 1980 Apr 30; 21():435-42. PubMed ID: 6103653
    [Abstract] [Full Text] [Related]

  • 7. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
    Reynolds GP, Rossor MN, Iversen LL.
    J Neural Transm Suppl; 1983 Apr 30; 18():273-7. PubMed ID: 6135746
    [Abstract] [Full Text] [Related]

  • 8. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 30; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 9. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.
    Neuropsychopharmacology; 1987 Dec 30; 1(1):5-15. PubMed ID: 2908095
    [Abstract] [Full Text] [Related]

  • 10. Dopamine receptor pharmacology.
    Seeman P, Van Tol HH.
    Curr Opin Neurol Neurosurg; 1993 Aug 30; 6(4):602-8. PubMed ID: 8104554
    [Abstract] [Full Text] [Related]

  • 11. Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.
    Harrison-Read PE.
    J Psychopharmacol; 2009 Nov 30; 23(8):899-907. PubMed ID: 18635692
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptors in the central nervous system.
    Seeman P, Tedesco JL, Lee T, Chau-Wong M, Muller P, Bowles J, Whitaker PM, McManus C, Tittler M, Weinreich P, Friend WC, Brown GM.
    Fed Proc; 1978 Feb 30; 37(2):131-6. PubMed ID: 414936
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic receptor-blocking concentrations of neuroleptics.
    Seeman P.
    Int Clin Psychopharmacol; 1995 Sep 30; 10 Suppl 3():5-13. PubMed ID: 8866760
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor genes: new tools for molecular psychiatry.
    Niznik HB, Van Tol HH.
    J Psychiatry Neurosci; 1992 Oct 30; 17(4):158-80. PubMed ID: 1450188
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
    Seeman P, Guan HC, Nobrega J, Jiwa D, Markstein R, Balk JH, Picetti R, Borrelli E, Van Tol HH.
    Synapse; 1997 Feb 30; 25(2):137-46. PubMed ID: 9021894
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P.
    Neuropsychopharmacology; 1992 Dec 30; 7(4):261-84. PubMed ID: 1362057
    [Abstract] [Full Text] [Related]

  • 17. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN, Lexow N, Bird E, Winokur A.
    Synapse; 1988 Dec 30; 2(5):546-57. PubMed ID: 2973147
    [Abstract] [Full Text] [Related]

  • 18. Dopamine receptors and psychiatric drug treatment.
    Syvälahti EK.
    Ann Clin Res; 1988 Dec 30; 20(5):340-7. PubMed ID: 2905878
    [Abstract] [Full Text] [Related]

  • 19. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE.
    Synapse; 1997 Nov 30; 27(3):168-76. PubMed ID: 9329152
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG, Cotterell DJ, Dubocovich ML.
    J Pharmacol Exp Ther; 1987 Dec 30; 243(3):857-67. PubMed ID: 2961878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.